annual CFF:
$116.14M-$87.11M(-42.86%)Summary
- As of today (June 17, 2025), MLYS annual cash flow from financing activities is $116.14 million, with the most recent change of -$87.11 million (-42.86%) on December 31, 2024.
- During the last 3 years, MLYS annual CFF has risen by +$92.33 million (+387.75%).
- MLYS annual CFF is now -42.86% below its all-time high of $203.25 million, reached on December 31, 2023.
Performance
MLYS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$189.28M+$189.19M(+210210.00%)Summary
- As of today (June 17, 2025), MLYS quarterly cash flow from financing activities is $189.28 million, with the most recent change of +$189.19 million (+210210.00%) on March 31, 2025.
- Over the past year, MLYS quarterly CFF has increased by +$73.07 million (+62.88%).
- MLYS quarterly CFF is now -7.02% below its all-time high of $203.57 million, reached on March 31, 2023.
Performance
MLYS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$189.22M+$73.07M(+62.92%)Summary
- As of today (June 17, 2025), MLYS TTM cash flow from financing activities is $189.22 million, with the most recent change of +$73.07 million (+62.92%) on March 31, 2025.
- Over the past year, MLYS TTM CFF has increased by +$73.33 million (+63.28%).
- MLYS TTM CFF is now -40.79% below its all-time high of $319.59 million, reached on March 31, 2023.
Performance
MLYS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MLYS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.9% | +62.9% | +63.3% |
| 3 y3 years | +387.8% | +1477.7% | +1477.2% |
| 5 y5 years | +2932.4% | - | - |
MLYS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.9% | +387.8% | -7.0% | >+9999.0% | -40.8% | +63.3% |
| 5 y | 5-year | -42.9% | +2932.4% | -7.0% | >+9999.0% | -40.8% | +1477.2% |
| alltime | all time | -42.9% | +2932.4% | -7.0% | >+9999.0% | -40.8% | +1477.2% |
MLYS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $189.28M(>+9900.0%) | $189.22M(+62.9%) |
| Dec 2024 | $116.14M(-42.9%) | $90.00K(-9100.0%) | $116.14M(+0.0%) |
| Sep 2024 | - | -$1000.00(-99.3%) | $116.13M(-0.2%) |
| Jun 2024 | - | -$152.00K(-100.1%) | $116.31M(+0.4%) |
| Mar 2024 | - | $116.20M(>+9900.0%) | $115.88M(-43.0%) |
| Dec 2023 | $203.25M | $74.00K(-59.8%) | $203.25M(+0.6%) |
| Sep 2023 | - | $184.00K(-131.7%) | $202.11M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$581.00K(-100.3%) | $201.36M(-37.0%) |
| Mar 2023 | - | $203.57M(<-9900.0%) | $319.59M(+149.6%) |
| Dec 2022 | $128.02M(+437.6%) | -$1.07M(+90.4%) | $128.02M(-0.8%) |
| Sep 2022 | - | -$561.00K(-100.5%) | $129.09M(-0.4%) |
| Jun 2022 | - | $117.65M(+880.7%) | $129.65M(+980.7%) |
| Mar 2022 | - | $12.00M | $12.00M |
| Dec 2021 | $23.81M(+521.7%) | - | - |
| Dec 2020 | $3.83M | - | - |
FAQ
- What is Mineralys Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual CFF year-on-year change?
- What is Mineralys Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly CFF year-on-year change?
- What is Mineralys Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM CFF year-on-year change?
What is Mineralys Therapeutics annual cash flow from financing activities?
The current annual CFF of MLYS is $116.14M
What is the all time high annual CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual cash flow from financing activities is $203.25M
What is Mineralys Therapeutics annual CFF year-on-year change?
Over the past year, MLYS annual cash flow from financing activities has changed by -$87.11M (-42.86%)
What is Mineralys Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MLYS is $189.28M
What is the all time high quarterly CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly cash flow from financing activities is $203.57M
What is Mineralys Therapeutics quarterly CFF year-on-year change?
Over the past year, MLYS quarterly cash flow from financing activities has changed by +$73.07M (+62.88%)
What is Mineralys Therapeutics TTM cash flow from financing activities?
The current TTM CFF of MLYS is $189.22M
What is the all time high TTM CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM cash flow from financing activities is $319.59M
What is Mineralys Therapeutics TTM CFF year-on-year change?
Over the past year, MLYS TTM cash flow from financing activities has changed by +$73.33M (+63.28%)